A Randomized, Parallel-Group, Open-Label, Multicenter Study to Assess the Potential for Adrenal Suppression and Systemic Drug Absorption Following Multiple Dosing with a New Lower-Concentration (0.025%) Clobetasol Propionate Cream. J of Skin. 2018;2:S83. doi:10.25251/skin.2.supp.84